ICMR distances itself from BHU's Covaxin study

The Indian Council of Medical Research (ICMR) has criticised Banaras Hindu University (BHU) researchers for incorrectly associating them with an observational study on the side effects of Bharat Biotech's Covid-19 vaccine, Covaxin. The study, which covered a one-year period after the vaccine was administered, found that nearly a third of the 926 participants reported adverse events of special interest (AESI).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/SvFLQCN
via IFTTT